CEO Andrew Semple: Human Health and Technology
CEO Andrew Semple Discusses His roles and Leadership in Human Health and TechnologyBRADENTON, FL / ACCESSWIRE / February 22, 2022...
Year: 2022
Net Medical Announces Preliminary Results for Fourth Quarter 2021
Leaning on two decades of experience connecting providers with the patients who need them, Net Medical's business is unique and...
Phonak Announces New Virto Paradise Line of Custom-made Hearing Aids
STÄFA, SWITZERLAND / ACCESSWIRE / February 22, 2022 / Phonak, a leading global provider of life-changing hearing solutions, today announces...
MediOrbis Announces Expanded Behavioral and Mental Health Support Programs
Specialty Telemedicine Programs to Include Comprehensive Mental Health for Self-Insured Employers, Private and Government Payers & Providers WorldwideCLEVELAND, OH /...
Solo-Dex Announces Agreement for Continuous Peripheral Nerve Block Catheters with InfuSystem
WOLF CREEK, MT / ACCESSWIRE / February 22, 2022 / Solo-Dex, Inc. today announced a national distribution agreement for its...
Secarna Pharmaceuticals’ Partner Denali Therapeutics Exercises Option for LNAplusTM Antisense Oligonucleotide Development Program in Neurodegeneration
First development program for which Denali exercised an option under the ongoing and recently expanded collaborationSecarna's LNAplusTM antisense oligonucleotides (ASOs)...
Delcath Systems Announces Move to a Direct Sales & Marketing Model for CHEMOSAT®
NEW YORK, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the...
Progenity Shares Two Poster Presentations on Treatment of Gastrointestinal Disorders at ECCO’22
Patient data establishes key correlations for therapeutic exposure in tissue and alternative inflammatory pathways, supporting the hypotheses of targeted therapeutic...
Optimi Health Launches E-Commerce Platform Featuring All-Natural Functional Mushroom Supplements
--B.C. company brings highest quality fruiting body mushroom formulations to the Canadian nutraceutical marketVANCOUVER, British Columbia., Feb. 22, 2022 (GLOBE...
Sorrento Announces COVISHIELD (STI-9167) Antibody Strongly Neutralizes BA.2 Omicron Sublineage Virus as Well as BA.1 and BA.1+R346k Omicron Viruses
STI-9167 neutralizing antibody (nAb) maintains high neutralization potency against the recently emerging Omicron sublineage BA.2 as was previously demonstrated for...
Quotient Limited to Participate in the Cowen 42nd Annual Health Care Conference
JERSEY, Channel Islands, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced...
Praxis Precision Medicines to Provide Corporate Update and Report Fourth Quarter and Full Year 2021 Financial Results on Monday, February 28, 2022
BOSTON, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights...
Allied Corp Commends the Colombian Government for Passing Regulations that Advance the Export of Dried Cannabis Flower From Colombia
KELOWNA, British Columbia., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to...
QuantuMDx announces approval of its Rapid Q-POCTM SARS-CoV-2 assay in the UK under CTDA legislation
QuantuMDx announces approval of its Rapid Q-POCTMSARS-CoV-2 assay in the UK under CTDA legislation NEWCASTLE UPON TYNE, UK, 22 February...
Nuvectis Announces Positive Data for NXP900 in Triple Negative Breast Cancer Preclinical Models with an Integrin-Linked Kinase (ILK) Loss
Data Published in Cancer Research, a journal of the American Association for Cancer Research Publication highlights potent activity of NXP900,...
World’s First Clinical Trial for DMT-Assisted Therapy in Major Depressive Disorder Shows Consistent Quality of Psychedelic Response in Phase I
In the Phase I clinical trial, participants were administered SPL026 and underwent a 20-minute psychedelic experience Phase I full dataset...
Sarepta Therapeutics to Announce Fourth Quarter and Full-Year 2021 Financial Results and Recent Corporate Developments on March 1, 2022
CAMBRIDGE, Mass., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare...
Teladoc Health Releases Annual Corporate Social Responsibility Report
Report Underscores Company’s Expanding Commitment to Being the ”Great Equalizer” in HealthcarePURCHASE, NY, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Teladoc...
Acer Therapeutics Announces Appointment of Adrian Quartel, M.D., FFPM, as Chief Medical Officer
Industry veteran with over 20 years of drug development experience to oversee advancement of Acer’s product pipeline Adrian Quartel, MD,...
Albireo to Report Q4 and Year-End 2021 Financial Results on March 1
— Conference call and webcast to be held at 10:00 a.m. ET —BOSTON, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Albireo...